StockData
Innospec Inc. logo

Innospec Inc. (IOSP) stock

IOSPNasdaqChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3022% below fair value
$75.56−1.52 (-1.97%)

Close on Nov 20, 2026Market cap $1.86BP/E –Yield 2.26%

Innospec gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Innospec's gross profit for the twelve months ending Jun 30, 2026 was $505.90M, down 0.5% year over year. For fiscal 2025 it was $492.40M, down 9.3% from the year before. Over ten years it grew 3.6% a year on average. The highest annual figure on record is $591.10M in fiscal 2023.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$492.40M-9.3%
FY2024Dec 31, 2024$542.90M-8.2%
FY2023Dec 31, 2023$591.10M+0.7%
FY2022Dec 31, 2022$586.70M+34.9%
FY2021Dec 31, 2021$434.90M+26.9%
FY2020Dec 31, 2020$342.70M-26.5%
FY2019Dec 31, 2019$466.20M+7.2%
FY2018Dec 31, 2018$435.00M+7.9%
FY2017Dec 31, 2017$403.30M+21.4%
FY2016Dec 31, 2016$332.30M-4.0%
FY2015Dec 31, 2015$346.00M+14.6%
FY2014Dec 31, 2014$302.00M+18.3%
FY2013Dec 31, 2013$255.20M+8.0%
FY2012Dec 31, 2012$236.40M+4.4%
FY2011Dec 31, 2011$226.40M+5.7%
FY2010Dec 31, 2010$214.10M+15.0%
FY2009Dec 31, 2009$186.20M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$138.30M+12.3%
Q1 FY2026Mar 31, 2026$123.50M-1.3%
Q4 FY2025Dec 31, 2025$127.40M-6.5%
Q3 FY2025Sep 30, 2025$116.70M-6.0%
Q2 FY2025Jun 30, 2025$123.20M-2.9%
Q1 FY2025Mar 31, 2025$125.10M-19.7%
Q4 FY2024Dec 31, 2024$136.20M-12.5%
Q3 FY2024Sep 30, 2024$124.10M-9.5%
Q2 FY2024Jun 30, 2024$126.90M-15.6%
Q1 FY2024Mar 31, 2024$155.70M+5.3%
Q4 FY2023Dec 31, 2023$155.70M+2.7%
Q3 FY2023Sep 30, 2023$137.20M-12.1%
Q2 FY2023Jun 30, 2023$150.40M+7.6%
Q1 FY2023Mar 31, 2023$147.80M+6.1%
Q4 FY2022Dec 31, 2022$151.60M+34.3%
Q3 FY2022Sep 30, 2022$156.00M+38.2%
Q2 FY2022Jun 30, 2022$139.80M+29.1%
Q1 FY2022Mar 31, 2022$139.30M+38.2%
Q4 FY2021Dec 31, 2021$112.90M+24.1%
Q3 FY2021Sep 30, 2021$112.90M+43.5%
Q2 FY2021Jun 30, 2021$108.30M+83.2%
Q1 FY2021Mar 31, 2021$100.80M-11.5%
Q4 FY2020Dec 31, 2020$91.00M-23.0%
Q3 FY2020Sep 30, 2020$78.70M-33.9%
Q2 FY2020Jun 30, 2020$59.10M-46.8%
Q1 FY2020Mar 31, 2020$113.90M-3.3%
Q4 FY2019Dec 31, 2019$118.20M+1.3%
Q3 FY2019Sep 30, 2019$119.10M+7.3%
Q2 FY2019Jun 30, 2019$111.10M+8.1%
Q1 FY2019Mar 31, 2019$117.80M+12.7%
Q4 FY2018Dec 31, 2018$116.70M+7.6%
Q3 FY2018Sep 30, 2018$111.00M+12.3%
Q2 FY2018Jun 30, 2018$102.80M-2.2%
Q1 FY2018Mar 31, 2018$104.50M+15.0%
Q4 FY2017Dec 31, 2017$108.50M+18.7%
Q3 FY2017Sep 30, 2017$98.80M+24.7%
Q2 FY2017Jun 30, 2017$105.10M–
Q1 FY2017Mar 31, 2017$90.90M–
Q4 FY2016Dec 31, 2016$91.40M–
Q3 FY2016Sep 30, 2016$79.20M–

More Innospec figures

See a number that looks wrong?